148 related articles for article (PubMed ID: 37763724)
1. Ophthalmological Manifestations in People with HIV from Northeastern Romania.
Cobaschi M; Loghin II; Dorobăț VD; Silvaș G; Rusu ȘA; Hârtie V; Aramă V
Medicina (Kaunas); 2023 Sep; 59(9):. PubMed ID: 37763724
[No Abstract] [Full Text] [Related]
2. Ocular manifestations of HIV infection.
Jabs DA
Trans Am Ophthalmol Soc; 1995; 93():623-83. PubMed ID: 8719695
[TBL] [Abstract][Full Text] [Related]
3. Study of prevalence of ocular manifestations in HIV positive patients.
Saini N; Hasija S; Kaur P; Kaur M; Pathania V; Singh A
Nepal J Ophthalmol; 2019 Jan; 11(21):11-18. PubMed ID: 31523061
[TBL] [Abstract][Full Text] [Related]
4. Posterior segment ocular manifestations of HIV/AIDS patients.
Chiotan C; Radu L; Serban R; Cornăcel C; Cioboată M; Anghelie A
J Med Life; 2014 Sep; 7(3):399-402. PubMed ID: 25408764
[TBL] [Abstract][Full Text] [Related]
5. [Diagnosis and treatment of eye diseases associated with HIV infection and AIDS].
Geng S; Ye JJ; Liu LQ; Xu HY; Wang WW; Wang SR
Zhonghua Yan Ke Za Zhi; 2009 Dec; 45(12):1093-8. PubMed ID: 20193432
[TBL] [Abstract][Full Text] [Related]
6. Ophthalmic manifestations of HIV infections in India in the era of HAART: analysis of 100 consecutive patients evaluated at a tertiary eye care center in India.
Gharai S; Venkatesh P; Garg S; Sharma SK; Vohra R
Ophthalmic Epidemiol; 2008; 15(4):264-71. PubMed ID: 18780260
[TBL] [Abstract][Full Text] [Related]
7. Cystoid macular oedema and cytomegalovirus retinitis in patients with HIV disease treated with highly active antiretroviral therapy.
Cassoux N; Lumbroso L; Bodaghi B; Zazoun L; Katlama C; LeHoang P
Br J Ophthalmol; 1999 Jan; 83(1):47-9. PubMed ID: 10209434
[TBL] [Abstract][Full Text] [Related]
8. Ocular manifestations in patients attending antiretroviral therapy centre at a tertiary care hospital in Himachal Pradesh, India.
Sharma M; Chauhan A; Sharma G; Chauhan V
Indian J Med Res; 2018 May; 147(5):496-500. PubMed ID: 30082574
[TBL] [Abstract][Full Text] [Related]
9. A cross-sectional study of cytomegalovirus retinitis in HIV-1 infected adults in Nigeria.
Adeiza MA; Habib AG
Niger J Clin Pract; 2019 Mar; 22(3):293-297. PubMed ID: 30837414
[TBL] [Abstract][Full Text] [Related]
10. Routine Eye Screening by an Ophthalmologist Is Clinically Useful for HIV-1-Infected Patients with CD4 Count Less than 200 /μL.
Nishijima T; Yashiro S; Teruya K; Kikuchi Y; Katai N; Oka S; Gatanaga H
PLoS One; 2015; 10(9):e0136747. PubMed ID: 26375282
[TBL] [Abstract][Full Text] [Related]
11. Cytomegalovirus retinitis in HIV/AIDS patients.
Chiotan C; Radu L; Serban R; Cornăcel C; Cioboata M; Anghel A
J Med Life; 2014 Jun; 7(2):237-40. PubMed ID: 25408732
[TBL] [Abstract][Full Text] [Related]
12. [Indications for eye examination of HIV patients--screening parameters for cytomegalovirus retinitis].
Gellrich MM; Lagrèze WD; Rump JA; Hansen LL
Klin Monbl Augenheilkd; 1996; 209(2-3):72-8. PubMed ID: 8992086
[TBL] [Abstract][Full Text] [Related]
13. Highly active antiretroviral therapy-associated regression of cytomegalovirus retinitis: long-Term results in a small case series.
Reed JB; Briggs JW; McDonald JC; Freeman WR; Morse LS
Retina; 2001; 21(4):339-43. PubMed ID: 11508879
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of untreated AIDS-related cytomegalovirus retinitis. II. Findings in the era of highly active antiretroviral therapy (1997 to 2000).
Holland GN; Vaudaux JD; Shiramizu KM; Yu F; Goldenberg DT; Gupta A; Carlson M; Read RW; Novack RD; Kuppermann BD;
Am J Ophthalmol; 2008 Jan; 145(1):12-22. PubMed ID: 18154751
[TBL] [Abstract][Full Text] [Related]
15. Ophthalmic manifestations and risk factors for mortality of HIV patients in the post-highly active anti-retroviral therapy era.
Lai TY; Wong RL; Luk FO; Chow VW; Chan CK; Lam DS
Clin Exp Ophthalmol; 2011 Mar; 39(2):99-104. PubMed ID: 20796263
[TBL] [Abstract][Full Text] [Related]
16. Sociodemographic predictors associated with the spectrum of non-opportunist neuroretinal disease of non-infectious etiology in patients with HIV/AIDS: A scoping review.
Gómez-Gualdrón SA; Sánchez-Uzcátegui MA; Camacho-López PA
Arch Soc Esp Oftalmol (Engl Ed); 2022 May; 97(5):251-263. PubMed ID: 35526949
[TBL] [Abstract][Full Text] [Related]
17. Discontinuation of maintenance therapy for cytomegalovirus retinitis in HIV-infected patients receiving highly active antiretroviral therapy.
Jouan M; Savès M; Tubiana R; Carcelain G; Cassoux N; Aubron-Olivier C; Fillet AM; Nciri M; Sénéchal B; Chêne G; Tural C; Lasry S; Autran B; Katlama C;
AIDS; 2001 Jan; 15(1):23-31. PubMed ID: 11192865
[TBL] [Abstract][Full Text] [Related]
18. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy in HIV infected patients: natural history and clinical predictors.
Lin DY; Warren JF; Lazzeroni LC; Wolitz RA; Mansour SE
Retina; 2002 Jun; 22(3):268-77. PubMed ID: 12055458
[TBL] [Abstract][Full Text] [Related]
19. AIDS and ophthalmology: the first quarter century.
Holland GN
Am J Ophthalmol; 2008 Mar; 145(3):397-408. PubMed ID: 18282490
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
